Curiox Biosystems

Curiox Biosystems

생명공학 연구

Transforming the landscape of cell sample preparation and bringing personalized automation to every scientist

소개

Curiox Biosystems is committed to enabling accurate biological analysis through automation. Next-generation methods and applications--including single-cell 'omics technologies, flow cytometry, immunotherapy, and cell and gene therapy--deserve a next-generation approach to preparing samples for analysis. That’s why Curiox invented Laminar Wash technology, the only sample preparation method that eliminates centrifugation and the problems it introduces. The methodology keeps cells in their native state, improves cell retention and viability, and enhances reproducibility and miniaturization, ultimately leading to reduced costs and workflow standardization.

업계
생명공학 연구
회사 규모
직원 51-200명
본사
Singapore
유형
비상장기업
설립
2008
전문 분야
Cell-based assays, Wash-based suspension cell assays, Primary cell screens, Assay miniaturization, centrifuge, immunology, Covid, Biosafety, sample preparation, automation, antibody discovery, cell therapy, immunoassays, flow cytometry, mass cytometry, single cell, proteogenomics, SEQ, cytof, fluidigm, 10x genomics, phenotyping, oncology, clinical 및 Research and development

위치

Curiox Biosystems 직원

업데이트

비슷한 페이지

자금조달

Curiox Biosystems 총 2라운드

마지막 라운드

시리즈 C

US$15,000,000.00

크런치베이스에서 자세히 알아보기